Real-World data shows Tivozanib's promise in kidney cancer fight
NCT ID NCT07354282
First seen Feb 01, 2026 · Last updated May 23, 2026 · Updated 15 times
Summary
This study reviewed medical records of 200 adults with advanced clear cell kidney cancer who received tivozanib as their first treatment. Researchers measured how long patients lived without the cancer getting worse. The goal was to see how well the drug works in everyday medical practice.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL CELL CANCER METASTATIC are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Fundacion Jimenez Diaz
Madrid, Madrid, Spain
-
Hospital Gregorio Marañon
Madrid, Madrid, Spain
-
Hospital Lucus Augusti
Lugo, Galicia, Spain
-
Hospital Parc Tauli
Sabadell, Catalonia, Spain
-
Hospital Puerta de Hierro
Majadahonda, Madrid, Spain
-
Hospital Reina Sofia
Córdoba, Andalusia, Spain
-
Hospital Severo Ochoa
Leganés, Madrid, Spain
-
Hospital Vall de Hebron
Barcelona, Catalonia, Spain
-
Hospital Virgen de la Victoria
Málaga, Andalusia, Spain
-
Hospital Virgen del Rocio
Seville, Andalusia, Spain
-
Hospital de Burgos
Burgos, Castille and León, Spain
-
Hospital de Leon
León, Castille and León, Spain
-
Institut Català d'Oncologia (ICO) de L'Hospitalet de Llobregat
L'Hospitalet de Llobregat, Catalonia, Spain
-
Instituto Valenciano de Oncologia (IVO)
Valencia, Valencia, Spain
Conditions
Explore the condition pages connected to this study.